Managing Lung Cancer in Young Adults: Not a Sprint, But a Marathon
Experts outline the gamut that clinicians must run to keep patients ages <70 on track
Related Articles
Here’s How We Know Vaccines Are Safe and Effective
Novel U.S. vaccines are tested against placebos, despite recent suggestions to the contrary
Flare and Persistently Active Disease in a Large Multinational Lupus Cohort
In contrast to relapsing‐remitting patterns, persistently active disease (PAD) is a disease activity pattern in patients with systemic lupus erythematosus (SLE) that is inadequately studied.…
In Colon Cancer, has a Better Predictor for Metastasis Been Identified? – Metastatic Colorectal Cancer in Focus
According to the results of a new study from Japan, the size of lymph nodes on preoperative computed tomography in patients with resectable colon cancer…
‘A Valuable Set of Tools’ To Improve Trials and Treatments in Acute Severe UC
Acute severe ulcerative colitis (ASUC) is associated with a significant risk of colectomy and requires timely and effective medical intervention to reduce morbidity and mortality.…
Opinion | Test Scores Never Defined My Competence as an Effective Clinician
Accreditation must remain independent to protect equity in medicine
Tezepelumab Cuts Oral Corticosteroid Use in Severe Asthma
Single-arm trial shows steroid-sparing for most patients
BP Lowering-Cancer Link Debunked; Cannabidiol’s Safety; Heart Failure Checkups MIA
Recent developments of interest in cardiovascular medicine
Zasocitinib Showed Efficacy and Safety After Phase 2 RCT
Zasocitinib, a tyrosine kinase 2 (TYK2) inhibitor, holds promise as a new oral treatment for psoriasis, randomized clinical trial data suggest. Results of the multisite…
Opinion | Does It Matter if the U.S. Surgeon General Never Practiced Medicine?
Their leadership must be grounded in sound public health priorities